chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt states that she can't move her left arm since got the flu shot and it has gotten worse since. Has pain in the left arm since she has gotten the shot.
Pt vaccinated with MMR developed back ache, side hurting, muscle spasms, headache and leg also hurting.  Seen by several Dr.'s.
I got lumps underneath of the left arm up to the front. I had shingles in that same area, but it was like I had them again all irritated. The lumps began a week after the dose and lasted until the second dose, three weeks on 04/13/2021.
my dermatologist diagnosed me with a form of dermatitis; triamcinolone for itching; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS (my dermatologist diagnosed me with a form of dermatitis) and PRURITUS (triamcinolone for itching) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 013L20A) for COVID-19 vaccination.    Co-suspect product included non-company product PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]) for an unknown indication.    No medical history was reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] and PRAVASTATIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]) (unknown route) at an unspecified dose. On 01-Apr-2021, the patient experienced DERMATITIS (my dermatologist diagnosed me with a form of dermatitis) and PRURITUS (triamcinolone for itching). The patient was treated with TRIAMCINOLONE at an unspecified dose and frequency. At the time of the report, DERMATITIS (my dermatologist diagnosed me with a form of dermatitis) and PRURITUS (triamcinolone for itching) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Skin test: Negative.         This case was linked to MOD-2021-101946 (Patient Link).
Two hours after shots developed hives on back, hips, stomach & shoulders. Accompanied by itching. Mom adm. 2 doses of homeopathic remedy and sx disappeared.
Immediately after administration, patient slumped forward to the left side and started moaning. This lasted several seconds. Upon sitting him up right, his eyes rolled back and he started shaking (seizing). This lasted several seconds. He then asked "what happened?" His B/P at that time was 95/53.
DIARRHEA; VOMITING; DIZZINESS; WEIRD SMELL; SEEING DOUBLE; PAIN FROM EYEBALLS ALL THE WAY DOWN TO TOES ON LEFT SIDE OF BODY; SWEATING; CHILLS; SORE ARM; FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 205A21A, expiry: UNKNOWN) dose was not reported, administered on 12-JUN-2021 17:45 for prophylactic vaccination. Concomitant medications included diphenhydramine hydrochloride, and famotidine. On 13-JUN-2021, the subject experienced dizziness. On 13-JUN-2021, the subject experienced weird smell. On 13-JUN-2021, the subject experienced seeing double. On 13-JUN-2021, the subject experienced pain from eyeballs all the way down to toes on left side of body. On 13-JUN-2021, the subject experienced sweating. On 13-JUN-2021, the subject experienced chills. On 13-JUN-2021, the subject experienced sore arm. On 13-JUN-2021, the subject experienced fever. On 13-JUN-2021, the subject experienced nausea. On 13-JUN-2021, the subject experienced headache. On 14-JUN-2021, the subject experienced diarrhea. On 14-JUN-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, and sore arm on 14-JUN-2021, was recovering from nausea, and diarrhea, and had not recovered from fever, dizziness, weird smell, seeing double, pain from eyeballs all the way down to toes on left side of body, sweating, chills, and headache. This report was non-serious.
Hep B3 administered 1/16/02 at 3pm. Developed fever, chills, sore throat, ear ache, sinus headache (frontal) 24 hours after vaccine given.
10MAR93 day p/vax 1AM vomiting & inc temp 104.6R; to pvt MD 10AUG93 PM; sent home; then devel temp 105 w/wheezing then to ER;
Headache, Myalgia & NauseaVomiting Narrtive:
mom stated pt ran t104.6; took pt to hosp MD said it was vaccine related;
The shots did hurt a little in the beginning, but as time goes on, the pain has gotten much worse.      I can not lift my arms over my head or even do routine motions without pain'  The only time I have no pain is when my arms are completely still by my side.  It is very hard to get dressed, take a shower, wash  my hair' It has been 6 months since the first shot and 3 months since the second shot.  I have no relief.  I have tried, advil, aleve, aspercreme with lidocaine, emu oil = nothing helps.  My Dr doesn't have any answers, I called my insurance provider, and they suggested I contact you.
pt was fine @ 6PM 2AUG94; 10AM pt was unresponsive, taken to hosp, pt died 2AUG94; fever 102.9, runny nose autopsy was inconclusive -coronary failure pending further investigation;
Suspected vaccination failure/1st and 2nd doses in 2019 / had Shingles in 2021; Shingles; received Shingrix when she was 48 / prior to approval of Shingrixfor patients under 50; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had first outbreak of Shingles in 2020, refer case US2021254962).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and inappropriate age at vaccine administration. On an unknown date, the outcome of the vaccination failure and inappropriate age at vaccine administration were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided are as follows: The case was reported by patient's husband. The patient received both doses of Shingrix on an unknown arm in summer of 2019 (exact dates were unknown) when she was 48 years old prior to the FDA approval Shingrix for immunocompromised patients under 50 years of age which led inappropriate age at vaccine administration and had second outbreak of shingles in 2021. The caller did not ask for lot, expiration date and arm administered. The reporter did not have specific information on his wife's vaccine. Did not ask for consent because caller was not the patient. This case was considered as suspected vaccination failure since the detail regarding and laboratory test confirming shingles was unknown at the time of reporting.; Sender's Comments:  US-GSKCCFUS-Case-01242845_AE-72822: US-GLAXOSMITHKLINE-US2021254962:Same reporter, same product, same patient, case created for event that happened in another point in time
CHILLS; HEADACHE; FATIGUE; SORENESS/PAIN AT INJECTION SITE; FEELING HOT; SLEEPY; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the subject experienced feeling hot. On 05-APR-2021, the subject experienced sleepy. On 05-APR-2021, the subject experienced fatigue. On 05-APR-2021, the subject experienced soreness/pain at injection site. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache.  Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness/pain at injection site on 07-APR-2021, and had not recovered from fatigue, sleepy, headache, chills, and feeling hot. This report was non-serious.
She presents to the ED today with CC of shortness of breath for several days. Initial evaluation in the ED was remarkable for hypoxia responsive to supplemental oxygen for which she was ultimately stabilized on HFNC (60%/50L). Covid testing resulted as positive and the MICU triage team was consulted to evaluate the patient in the setting of newly diagnosed covid positive status and high oxygenation requirement.   Shortly after admission, patient with sudden witnessed respiratory arrest and bradycardia prompting CPR. Patient received x1 round of CPR and intubated by ED providers, on pulse check noted to be in PEA and given x1 epi with ROSC. Patient continued to be hypotensive requiring management with multiple vasopressors, however, PEA arrested requiring additional two rounds of CPR with ROSC.   Family verbalized patient be DNR/DNI at that time with transition to comfort care measures only. Both patient's son and granddaughter verbalized agreement with decision regarding patient's care management in making patient comfortable and removing all other invasive or life-sustaining measures. Patient then went into asystole and passed away shortly thereafter, TOD at 1950 with granddaughter present at bedside.
Received booster from a vial that was punctured 21 times; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Received booster from a vial that was punctured 21 times) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Received booster from a vial that was punctured 21 times). On 29-Nov-2021, PRODUCT ADMINISTRATION ERROR (Received booster from a vial that was punctured 21 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications and no treatment medications were reported.  Reporter stated that trying to identify which patient received the 21st booster dose. On 29 Nov 2021, 21 patients received the booster vaccine from 1 vial. On 22 Nov 2021 11:40AM vial moved from freezer to refrigerator. Vaccine state change: Liquid vaccine looked normal, No particulate matter in the syringe was reported. Vial was punctured too many times (21 times) and never had previous excursion   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2021: Follow-up Information received.Updated Reporter fax number and Email id.
inc temp, nasal drainage, cough, APAP, sudafed, fluids, flu dx;
diarrhea; stomach is very bad/lot of pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN UPPER (stomach is very bad/lot of pain) and DIARRHOEA (diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ABDOMINAL PAIN UPPER (stomach is very bad/lot of pain) (seriousness criterion hospitalization). On an unknown date, the patient experienced DIARRHOEA (diarrhea) (seriousness criterion hospitalization). At the time of the report, ABDOMINAL PAIN UPPER (stomach is very bad/lot of pain) and DIARRHOEA (diarrhea) had not resolved.            Concomitant medication usage was not reported.  Treatment information was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
itching was horrific; She scratched herself so much that there are streaks of blood on her bedsheets; 10 months of pure agony.; she started breaking out in a rash/ She broke out on her stomach and top of her arm and on her butt/ breaking out in her legs/She ended up with a rash from her neck down to her ankles; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching was horrific), SCRATCH (She scratched herself so much that there are streaks of blood on her bedsheets), DEPRESSED MOOD (10 months of pure agony.) and RASH (she started breaking out in a rash/ She broke out on her stomach and top of her arm and on her butt/ breaking out in her legs/She ended up with a rash from her neck down to her ankles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching was horrific), SCRATCH (She scratched herself so much that there are streaks of blood on her bedsheets), DEPRESSED MOOD (10 months of pure agony.) and RASH (she started breaking out in a rash/ She broke out on her stomach and top of her arm and on her butt/ breaking out in her legs/She ended up with a rash from her neck down to her ankles). The patient was treated with PREDNISONE ongoing since an unknown date for Rash and Itching, at a dose of 7 days left.. At the time of the report, PRURITUS (itching was horrific), SCRATCH (She scratched herself so much that there are streaks of blood on her bedsheets) and RASH (she started breaking out in a rash/ She broke out on her stomach and top of her arm and on her butt/ breaking out in her legs/She ended up with a rash from her neck down to her ankles) had resolved and DEPRESSED MOOD (10 months of pure agony.) outcome was unknown.            She started breaking out in a rash. She thought it was from straw and mulch. She went to 3 dermatologists, but they all scratched their heads and their butts not knowing what it was. The new dermatologist put her on prednisone, and all of the places have dried up but they'll leave scars. It made her potassium a little high, messed up some of her blood work.  No concomitant medication was provided.
felt very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced MALAISE (felt very sick). At the time of the report, MALAISE (felt very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD21-038351 (E2B Linked Report).; Sender's Comments:  MOD21-038351:
Patient reporting on day 4 after immunization, arm soreness, redness and warmth at injection site.  Patient states it appears to be getting better.
first dose in August 2020/second dose yesterday 26-JUL-2021; No additional AE's reported; she is just getting conflicting information from the doctor; This spontaneous report was received from a consumer calling on behalf of her son and refers to a 20-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unspecified date in August 2020, the patient received the first dose of the HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (formulation, strength, exact dose, anatomical location, route of administration, lot # and expiration date were not reported) for prophylaxis and for some reason got confused in terms of the schedule. The doctor never called them to schedule the next dose. Caller stated she ended up calling and scheduling the second dose herself. Caller wanted to confirm the schedule for doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). Yesterday on 26-JUL-2021, her son received the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (formulation, strength, exact dose, anatomical location, route of administration, lot # and expiration date were not reported) for prophylaxis and that was a time period of eleven months between the 1st and 2nd dose (inappropriate schedule of product administration). Caller wanted to know when does he get the third dose because she spoke to a doctor yesterday, they suggested she call us to know when to get the third one, and at first wanted them to start the series over. Caller stated the doctor called her back and said they did not need to start over, the first and second doses are cleared. Caller stated she is just getting conflicting information from the doctor (circumstance or information capable of leading to medication error) so she wanted to just confirm the dosing schedule since her son was late receiving the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). No additional information was provided. No additional AE's reported (no adverse event). The outcome was unknown.
The first time went home normal reaction as everybody soreness  On 2nd or  third day my Body function was out of wacky it was twitching and shaking violently . Didn't think nothing of it. a couple of week I was getting painful spasm. I couldn't go to ER . I thought it was a pinch nerves.  I went to ER but I couldn't drive myself because I was jerking too much. The second one was the same thing. The third day after the second shot I went to the ER. feeling the same symptoms. I had pains in my neck. The Dr, was saying it had nothing to do with the Moderna. But I never had this problem before.
1 week after receiving first dose of Pfizer COVID vaccine (received 1/26/2021), develop worsening shortness of breath. Presented to ER on 2/4/2021. Found to have submassive pulmonary embolism with evidence of right heart strain, US showed left lower extremity DVT. Also found to have descending aortic thrombus with extensive clot burden.  Was hypoxic 89% on room air.
SORE ARM 8 HRS POST VACCINE. THEN, HEADACHES AND MALAISE. MINOR BODY ACHES UPON AWAKENING THE NEXT MORNING. ALL LASTED UNTIL ABOUT 28 HRS POST VACCINE.
This spontaneous case was reported by a consumer and describes the occurrence of TOOTH ABSCESS (Tooth abscess) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced TOOTH ABSCESS (Tooth abscess). The patient was treated with AMOXICILLIN on 18-Mar-2021 for Tooth abscess, at a dose of 10 daysUNK. At the time of the report, TOOTH ABSCESS (Tooth abscess) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Thyroid medicine(Unspecified).
Information has been received from a health professional concerning a 12 month old pt who in Apr 2005, was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccine administered on the same day included measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). It was reported that, shortly after receiving the vaccines, in Apr 2005, the pt developed 50 spots. It was noted that the doctor was not certain what the rash was and if it was caused by varicella virus vaccine live or measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Immediately after adminstering injection, patient started coughing, and clearing of throat. Patient denied  itching i n back of throat, states just feels like something is there. Denied any breathing issues, denied any problems with swallowing, throat swelling. Water provided tolerated drinking water without problems. coughing and clearing of throat continues, held a conservation during the hold process talking about family and friends. Continue to state it just like something was in the back of his throat. No changes in voice, no problems with breathing, no other issues.  He stated he felt fine just the coughing and the feeling some thing in his throat. Patient stayed with me for approximate 30 minutes until coughing subsided.  Instructed if problems with breathing to go to nearest ER. He acknowledged understanding.  On discharge gait steady no signs of distress.  After patient left Dr. and Rn here, explained issue. 5/17/22 called to check on patient, Daughter and spouse both states he is doing fine, he is doing house work, spouse stated she had the same problem with coughing after she got home after her shot on last week and then it went away. He has had no other issues since leaving the clinic. RN
I had a fever of 103.  Dizziness, muscle ache, chills.
Acute appendicitis; procedure - Laparoscopic Appendectomy. He was treated with 5 days of antibiotics IV and transitioned to p.o. Augmentin yesterday.  The patient tolerated the procedure(s) well and was transferred to the ward post operatively.  On POD #5 he developed acute urinary retention, Foley catheter was placed and he was started on oral Flomax.  Diet was advanced without difficulty.  At the time of discharge the patient was tolerating a General diet and having good pain control on oral analgesics. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.